Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa) is a research paper published in Clinical Infectious Diseases (2022). On theSindex it has a DataRank of 0.937. It has been cited 515 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.937
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Allergan
Grant: unidentified
unidentified
Astellas
AstraZeneca
Entasis Therapeutics
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Tetraphase and Steris
Veterans Health Administration
JAC-Antimicrobial Resistance
Pfizer
Sempra
CDC
European Society of Clinical Microbiology and Infectious Diseases
Paratek
Roche
Scynexis
Veterans Affairs Society for Prevention of Infectious Diseases
Antimicrobial Agents and Chemotherapy
British Society for Antimicrobial Chemotherapy
Medicines Company
Needham & Associates
Theravance
VenatoRx
Wockhardt
Shionogi
Achaogen
Allergan
Qpex Biopharma
Harrington Foundation
Rempex and Antimicrobial Resistance Services
mBio
Accelerate Diagnostics
Allecra
Cidara
Melinta
Merck
Wallace H. Coulter Endowment
Zavante
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals